Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.9500
-0.0100 (-1.04%)
At close: Jun 16, 2025

BOM:531752 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
-2.9319.314.56-0.09-16.03
Upgrade
Other Operating Activities
0---0-
Upgrade
Change in Accounts Receivable
---25.454.85
Upgrade
Change in Accounts Payable
--18.4-0.610.61
Upgrade
Change in Other Net Operating Assets
-7.980.14-5.91-10.730.07
Upgrade
Operating Cash Flow
-10.9119.4517.0413.9839.5
Upgrade
Operating Cash Flow Growth
-14.09%21.89%-64.60%-
Upgrade
Investment in Securities
-184.0134.1-1925.39-30.44
Upgrade
Investing Cash Flow
-326.1-20.56-16.59-13.23-36.4
Upgrade
Short-Term Debt Repaid
-----3.06
Upgrade
Total Debt Repaid
-----3.06
Upgrade
Net Debt Issued (Repaid)
-----3.06
Upgrade
Issuance of Common Stock
357----
Upgrade
Financing Cash Flow
357----3.06
Upgrade
Miscellaneous Cash Flow Adjustments
--0---
Upgrade
Net Cash Flow
19.99-1.120.460.760.04
Upgrade
Levered Free Cash Flow
-14.842.2511.2716.5854.95
Upgrade
Unlevered Free Cash Flow
-14.842.2511.2716.5854.95
Upgrade
Change in Net Working Capital
7.77-0.14-12.49-14.68-54.92
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.